AGTC
$3.20
Applied Genetic Tech
($.14)
(4.19%)
Earnings Details
2nd Quarter December 2019
Tweet Share Watch
Summary

Applied Genetic Tech (AGTC) Recent Earnings

Applied Genetic Tech (AGTC) reported a 2nd Quarter December 2019 loss of $0.47 per share on revenue of $2.5 million. The consensus estimate was a loss of $0.59 per share. Revenue fell 58.7% compared to the same quarter a year ago.

Applied Genetic Technologies Corp is a clinical-stage biotechnology company. It is primarily developing gene therapy products designed to transform the lives of patients with severe inherited orphan diseases in ophthalmology.

Results
Reported Earnings
($0.47)
Earnings Whisper
-
Consensus Estimate
($0.59)
Reported Revenue
$2.5 Mil
Revenue Estimate
Growth
Earnings Growth
Revenue Growth
Power Rating
Grade
Earnings Release